Brind.

A company, likely Amgen or Generate Biomedicines Inc, is leveraging the Chroma model for an AI platform, backed by co-development deals.

1 report, 1 independent Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A company, likely Amgen or Generate Biomedicines Inc, is leveraging the Chroma model for an AI platform, backed by co-development deals.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped